Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Pharmaceuticals

Sage Therapeutics Lead

Sage Therapeutics Rises After Swing to Profit on Biogen Deal

By Vidhi Choudhary

No More Tears for Johnson & Johnson?

Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing

By Martin Baccardax

New Medical Devices Steal the Show at South by Southwest's First Health Tech Expo

ICON to Buy PRA Health in $12 Billion Cash-and-Stock Deal

By M. Corey Goldman

Celsion Lead

Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug

By Dan Weil

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet

GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials

By Martin Baccardax

Australia, South Korea, Japan Lead Asia-Pacific Rally On Rising Hopes Lockdowns May Work Against The Coronavirus

Giving Pfizer a Shot: Virologist Gives His Take on the Jab in Japan

By Adam Smith

The government has already secured millions of doses of the Pfizer-BioNtech Covid-19 vaccine. Photo: AFP

COVID on Track to Kill a Half Million Americans

By Adam Smith

Tokyo Olympics Lead

Will Pfizer Shots Be the Ticket to the Tokyo Olympics?

By Adam Smith

Vaccinex Lead

Vaccinex Spikes on Deals with Two Pharma Companies

By Vidhi Choudhary

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Pfizer Seeks FDA Approval For Higher Coronavirus Vaccine Storage Temperatures

By Martin Baccardax

Invitae Lead

Invitae Lifted to Buy on Growth Potential and Cost Controls

By Rob Lenihan

Health Insurance Covid-19 Lead

Immunome Skyrockets on Isolation of COVID Antibodies

By Dan Weil

Rigel Lead

Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly

By Dan Weil

Vir Biotechnology Lead

Vir Biotech Jumps on New Drug Development Deal With GSK

By Dan Weil

Moderna Lead

Moderna Receives FDA Nod to Add More Vaccine to Vials: Report

By Dan Weil

HubSpot Is Spot On With Delivering Results to Investors and Customers

5 Top Stock Gainers for Friday: Fisker, HubSpot, Illumina

By Rob Lenihan

Trulieve Cannabis Lead

The Pot Stock Outlook is Hazy - Here's the Lowdown

Canadian Pot Legalization Could Be A Fresh Tailwind for Cannabis Stocks

Pot Stocks Stay Volatile - Here’s What’s Happening Friday

By M. Corey Goldman

Why Teva Pharmaceuticals Shares Are Losing Steam

Teva's Fourth-Quarter Adjusted Earnings Top Forecasts

By Dan Weil

Snap-On, Centene and Qlik Tech Will Shine in 2016 Says Palisade’s Veru

Veru Leaps on Progress With COVID-19 Treatment Trial

By Rob Lenihan

Chinese Biotech CStone On Course To Launch Lung Cancer Drug After Successful Clinical Trial

Heat Biologics Jumps on Progress With Lung-Cancer Drug

By Tony Owusu

medicare drug rx sh

KalVista Reports Positive Test Results for Angioedema Drug; Shares Soar

By Dan Weil

Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories

Eli Lilly CFO Smiley Resigns Over 'Inappropriate Relationship'

By Rob Lenihan

Carrie Lam on Thursday told Legco that public confidence in the government's vaccine programme would be boosted when delivery issues were resolved. Photo: Shutterstock

Eye-Drug Firm Ocugen Triples After Direct Offering

By Dan Weil

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.